ArticleMolecular biology reports2025
circ-Ttc3 alleviates LPS-induced neuronal injury via stabilizing RBFOX1 to inhibit inflammation and oxidative stress.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSpinal cord injury (SCI) leads to secondary neuronal damage through inflammation and oxidative stress, yet the underlying regulatory mechanisms remain incompletely understood. METHODS AND
resultsThis study identifies circ-Ttc3 as a protective regulator in SCI-associated neuronal injury using a lipopolysaccharide (LPS)-induced PC12 cell model. circ-Ttc3 expression was significantly downregulated following LPS treatment, while its overexpression restored cell viability, inhibited apoptosis, and suppressed proinflammatory cytokine expression and oxidative stress markers. Mechanistically, bioinformatics and RNA immunoprecipitation (RIP) assays identified RBFOX1 as a direct binding protein of circ-Ttc3. circ-Ttc3 increased RBFOX1 protein levels by enhancing its stability, as shown by cycloheximide chase assays. Functional rescue experiments further revealed that knockdown of RBFOX1 abrogated the protective effects of circ-Ttc3 on inflammation, oxidative stress, and neuronal apoptosis, supporting the existence of a circ-Ttc3/RBFOX1 regulatory axis. These findings demonstrate that circ-Ttc3 mitigates neuronal injury by stabilizing RBFOX1, thereby suppressing secondary injury mechanisms.
conclusionsThis study highlights a novel circRNA-RNA binding protein (RBP) interaction underlying neuroprotection in LPS-induced oxidative stress and inflammation, and provides new insight into potential therapeutic targets for SCI intervention.
Indexed as
Identifiers
41456226What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.